Technology: Who Gets to Invent, Who Gets to Use
The Machine They Would Not Let You Have
In 1774, the British Parliament passed a law making it a crime to export textile machinery. The penalty for attempting to ship a spinning jenny or a water frame out of England was heavy fines and imprisonment.
This was not about safety or standards. It was about power.
Britain had the most advanced textile technology in the world — the machines that could spin cotton into yarn and weave yarn into fabric faster and cheaper than any human hand. These machines were the source of Britain's industrial dominance, its export earnings, its wealth, its empire.
And Britain intended to keep them.
The law did not stop at machines. It also prohibited the emigration of skilled textile workers. If you knew how to build or operate the machines, you were not allowed to leave the country. Your knowledge was a national asset, and the state would imprison you for taking it elsewhere.
Despite these laws, a young mechanic named Samuel Slater memorized the designs of Richard Arkwright's water frame, disguised himself, boarded a ship, and sailed to America in 1789. He rebuilt the machines from memory in Rhode Island and launched the American textile industry.
In Britain, Slater was called a traitor. In America, he was called "the father of American manufacturing." Andrew Jackson called him "the father of American industry."
One man's traitor is another nation's founding industrialist.
This story — of technology hoarded by the powerful and stolen by the ambitious — is the story of economic development itself. And it is still happening, right now, in different forms.
Look Around You
Every object you use was, at some point, a revolutionary technology. The ballpoint pen was patented in 1938. The zipper took decades to perfect. The smartphone in your pocket contains technology that would have been classified military intelligence fifty years ago.
But here is the question most people never ask: who invented these things? Who holds the patents? Who profits from them? And who decides whether you can afford to use them?
When a farmer in Bihar uses a mobile phone to check crop prices, that phone contains technology developed in American, Japanese, Korean, and Chinese labs. The farmer pays for the phone. But the real profits flow to the companies that hold the patents and control the technology.
Technology is the great productivity multiplier. But it is also a source of power — and like all power, it is unequally distributed.
Technology as the Driver of Productivity
Let us be clear about why technology matters so much for economics.
Productivity — the amount of output you can produce with a given amount of labor and capital — is the single most important determinant of a country's living standards. And technology is the single most important driver of productivity.
A farmer with a wooden plow and a bullock can cultivate perhaps two acres. Give that farmer a tractor, and he can cultivate two hundred. The difference is not harder work or longer hours — it is technology.
A weaver with a hand loom can produce a few meters of cloth per day. A power loom produces hundreds of meters. A modern automated loom produces thousands. Each step is a technological leap that multiplies output by orders of magnitude.
The economist Robert Solow won the Nobel Prize for showing that most long-term economic growth — perhaps 80 percent or more — comes not from using more labor or more capital, but from technological improvement. More workers and more machines contribute, but technology is the dominant force.
This is why the question of who controls technology is so consequential. The countries that generate, own, and deploy technology are the productive ones. The countries that merely consume it are dependent ones.
"Technology is the answer. But what was the question?" — Cedric Price, architect (a reminder that technology must* *serve human purposes, not the reverse)
How Technology Spreads: The Diffusion Curve
New technologies do not appear everywhere at once. They follow a pattern — invented in one place, adopted slowly by early users, then spreading more widely, and eventually becoming universal.
This process is called technology diffusion, and it follows a characteristic S-curve:
TECHNOLOGY DIFFUSION: FROM INVENTION TO MASS ADOPTION
========================================================
% of population
using the technology
^
100%| ___________
| ***
| ***
| ***
| ***
50%| ***
| ***
| ***
| **
| **
| **
| **
0%|*
+---+---+---+---+---+---+---+---+---+---> Time
| | | | |
Invent Early Early Late Laggards
-ion Adopt- Majority Majority
ers
Phase 1: INVENTION
A few researchers, tinkerers, or companies
create the technology. It is expensive and crude.
Phase 2: EARLY ADOPTION
Wealthy users, advanced countries, and large
firms adopt it. The technology improves rapidly.
Prices begin to fall.
Phase 3: MASS ADOPTION
The technology becomes affordable and reliable
enough for widespread use. Prices fall sharply.
Most people in advanced countries adopt it.
Phase 4: UNIVERSAL ACCESS (or not)
The technology becomes cheap enough for
developing countries and poor users. This
phase often takes decades — and for many
technologies, it never fully arrives.
THE GAP between Phase 2 and Phase 4 is the
"technology divide." It is measured in years,
decades, or — for some technologies — never.
The telephone was invented in 1876. It took about fifty years to reach 50 percent of American households, and over a century to reach most of the world's population (in the form of mobile phones).
The internet was developed in the 1970s, became commercially available in the 1990s, and now reaches roughly 60 percent of the world's population — but 40 percent remain unconnected.
Each technology creates a window of advantage for those who have it and a period of disadvantage for those who do not. The countries and firms that are early adopters capture the profits. The latecomers pay for technology they did not develop and face competitors who have been using it for years.
Patents, Intellectual Property, and the Cost of Innovation
Here is where the story becomes politically charged.
Developing new technology is expensive. Pharmaceutical companies spend billions developing a new drug. Tech companies invest enormously in research and development. Designing a new semiconductor chip costs upward of a billion dollars.
To reward this investment, countries grant patents — legal monopolies that give inventors the exclusive right to produce and sell their invention for a limited period (usually twenty years).
The logic is reasonable: without patent protection, anyone could copy an invention without bearing the cost of developing it. This would remove the incentive to invest in innovation in the first place. Patents create a temporary monopoly to reward creativity.
But patents also have a dark side.
A patent allows the holder to charge whatever price they want for the duration of the monopoly. For luxury goods, this is merely annoying. For life-saving medicines, it is deadly.
Consider antiretroviral drugs for HIV/AIDS. When they were introduced in the mid-1990s, they cost $10,000 to $15,000 per patient per year. At those prices, they were available in the United States and Europe but completely unaffordable in sub-Saharan Africa — where the vast majority of HIV-positive people lived.
Millions died while patent-holding pharmaceutical companies earned enormous profits. The drugs existed. The knowledge to make them existed. What prevented access was not science but law — intellectual property law.
India's Generic Drug Revolution
India played a pivotal role in challenging the global patent system, and the story is one of the most consequential in modern economic history.
After independence, India's patent law (the Patents Act of 1970) was deliberately designed to prioritize public health over corporate profits. It allowed "process patents" but not "product patents" for pharmaceuticals. This meant that Indian companies could not copy the exact manufacturing process used by a Western drug company, but they could develop their own process to make the same drug.
Indian pharmaceutical companies — Cipla, Ranbaxy, Dr. Reddy's, and others — became extraordinarily good at this. They could produce generic versions of patented drugs at a fraction of the cost.
In 2001, the Indian company Cipla offered to supply antiretroviral drugs to Africa for $350 per patient per year — less than a dollar a day. The branded version cost $10,000.
This was not charity. Cipla was making a profit at $350. The difference between $350 and $10,000 was not the cost of producing the drug — it was the cost of the patent monopoly.
Cipla's offer — and the broader availability of Indian generic drugs — transformed the global response to HIV/AIDS. Today, Indian manufacturers supply over 80 percent of the antiretroviral drugs used in the developing world. Millions of people are alive because Indian companies broke the monopoly pricing of Western pharmaceutical firms.
"We decided that we would rather save lives and face legal consequences than watch people die to protect someone's patent." — Yusuf Hamied, chairman of Cipla
TRIPS: The Rules Tighten
India's generic drug industry existed because India's patent laws were permissive. The Western pharmaceutical industry wanted to change that.
The opportunity came with the creation of the World Trade Organization (WTO) in 1995. Attached to the WTO agreements was TRIPS — the Agreement on Trade-Related Aspects of Intellectual Property Rights.
TRIPS required all WTO member countries to adopt Western-style patent protections, including product patents for pharmaceuticals. For the first time, developing countries were legally required to respect the intellectual property of multinational corporations.
India had to amend its patent law by 2005. After that, Indian companies could no longer freely produce generic versions of newly patented drugs.
The implications were enormous. TRIPS was, in effect, an attempt by the countries that owned the technology to prevent the countries that needed it from accessing it on affordable terms.
Defenders of TRIPS argued that strong patent protection was necessary to incentivize innovation. Critics pointed out that most pharmaceutical innovation was focused on diseases of the rich (cholesterol drugs, weight loss pills) rather than diseases of the poor (malaria, tuberculosis), and that the patent system was designed to maximize profits, not to maximize health.
India's Section 3(d) — a provision in its amended patent law that prevents the patenting of minor modifications to existing drugs (a practice known as "evergreening") — became a battleground. In 2013, the Indian Supreme Court ruled against Novartis's attempt to patent a slightly modified version of its cancer drug Glivec, citing Section 3(d). The ruling was hailed by public health advocates worldwide and condemned by the pharmaceutical industry.
What Actually Happened
The tension between intellectual property and access to technology is one of the defining conflicts of the global economy.
During the COVID-19 pandemic, this conflict became acute. Vaccines were developed in record time, but access was radically unequal. Rich countries secured billions of doses through advance purchase agreements. Poor countries waited. India and South Africa proposed a temporary waiver of vaccine patents at the WTO — a proposal that the United States, the EU, and other vaccine-producing countries initially resisted.
The debate exposed the fundamental question: when a technology is essential for survival — whether it is a vaccine, an antiretroviral drug, or a climate-saving energy technology — should private property rights take precedence over public need?
The global patent system, as currently designed, says yes. The logic of human survival often says no.
This tension is not resolved. It is the terrain on which some of the most important economic battles of the coming decades will be fought.
Technology Transfer: How Countries Catch Up
Here is an uncomfortable truth about economic development: every country that has caught up technologically has done so, in part, by acquiring technology from more advanced countries. And the methods have often been legally dubious.
Britain stole from Asia. The technology for making porcelain, silk, and fine cotton textiles originated in China and India. European powers spent centuries trying to learn, copy, and adapt these technologies.
America stole from Britain. Samuel Slater was just the most famous case. The early American textile industry was built on stolen British designs. Alexander Hamilton explicitly advocated for the acquisition of foreign technology, by any means necessary.
Germany stole from Britain. German industrialists sent engineers to British factories to learn manufacturing techniques. The German chemical industry — which would become the world's most advanced — was built partly on knowledge acquired from British firms.
Japan copied the West systematically. During the Meiji era, Japan sent thousands of students and officials to study Western technology, industry, and institutions. It licensed technology where possible and reverse-engineered it where licensing was refused.
South Korea learned from Japan. Korean engineers worked in Japanese factories, studied Japanese methods, and adapted them for Korean conditions. Samsung's early electronics were based on Japanese designs.
China acquired technology from everyone. Through joint ventures, reverse engineering, industrial espionage, and forced technology transfer, China has built technological capabilities across every major industrial sector. Western companies complain, but China is following the same pattern that every previous industrializer followed.
The pattern is universal: catch-up requires technology transfer. And technology transfer is rarely voluntary on the part of the leader.
The countries that are now rich and technologically advanced acquired much of their foundational technology from others. They now insist that today's developing countries respect intellectual property rights that they themselves did not observe when they were developing.
This is another instance of kicking away the ladder.
"The history of technology transfer is the history of industrial espionage, state-sponsored theft, and strategic acquisition — dressed up, after the fact, as innovation."
The Digital Divide
The latest frontier of technology inequality is digital.
The internet, mobile computing, artificial intelligence, cloud services, and data analytics are transforming every industry and every aspect of life. Countries and people with access to these technologies are pulling ahead. Those without are falling further behind.
The digital divide operates at multiple levels.
Between countries. The United States, China, South Korea, and a handful of other countries dominate the digital economy. They are home to the tech giants — Google, Amazon, Facebook, Apple, Microsoft, Alibaba, Tencent, Baidu — that control the platforms, the data, and the algorithms.
Most developing countries are consumers of digital technology, not producers. They use American platforms, run on American operating systems, and store their data on American or Chinese servers. They are, in the digital economy, what colonies were in the old economy — providers of raw material (data) and consumers of finished goods (apps and services).
Within countries. In India, the digital divide separates urban and rural, English-speaking and non-English-speaking, college- educated and not. The same smartphone that connects a Bangalore engineer to the global economy is, for a Bihar farmer, primarily a tool for phone calls and WhatsApp — valuable, but not transformative in the same way.
Between generations. Older workers who did not grow up with digital technology are increasingly at a disadvantage in labor markets that prize digital skills. This is true in rich and poor countries alike.
The digital divide matters because the digital economy increasingly determines who prospers. As more economic activity moves online — e-commerce, financial services, education, healthcare — those without digital access or digital skills are excluded from growing portions of the economy.
Who Owns the Future?
The control of technology — who invents it, who patents it, who manufactures it, who deploys it — is the central question of the twenty-first-century economy.
Consider a few examples.
Semiconductors. The tiny chips that power every digital device are manufactured by a handful of companies — primarily TSMC (Taiwan), Samsung (South Korea), and Intel (United States). The equipment to make advanced chips is made by ASML, a single Dutch company. No country can build advanced technology without access to these chips, and access can be cut off for geopolitical reasons, as the US has done with China.
Artificial intelligence. AI is being developed primarily in the US and China. The computing power required is enormous, the datasets are vast, and the expertise is concentrated. Countries that do not develop AI capabilities risk becoming dependent on those that do — for everything from medical diagnosis to military strategy.
Renewable energy technology. China dominates the production of solar panels, lithium-ion batteries, and electric vehicles. As the world transitions to renewable energy, China's technological leadership in this space gives it enormous economic and strategic leverage.
Biotechnology. Gene editing (CRISPR), synthetic biology, and advanced pharmaceuticals are concentrated in a small number of countries and companies. The ability to engineer biology — to create new drugs, new crops, new materials — will be a defining capability of the coming decades.
In each case, the pattern is the same: technology is concentrated, the countries that control it have power, and the countries that do not are dependent.
Think About It
Samuel Slater is celebrated in America and condemned in Britain for the same act — transferring technology. When China acquires Western technology, the West calls it theft. Is it? How is it different from what Slater did?
Should life-saving medicines be subject to patent protection? If not, how would you incentivize pharmaceutical companies to invest in developing new drugs?
India's generic drug industry saves millions of lives but earns India criticism from Western pharmaceutical companies. How should India navigate between public health and international trade obligations?
The digital divide means that some children grow up with access to the world's knowledge and others do not. What are the economic consequences of this divide, a generation from now?
If technology is the main driver of productivity, and productivity is the main driver of wealth, then whoever controls technology controls wealth. Do you agree? What should developing countries do about it?
The Innovation Dilemma for Developing Countries
Developing countries face a painful choice.
They need technology to develop. Without modern technology — in agriculture, manufacturing, healthcare, energy, digital services — they cannot raise productivity, create good jobs, or improve living standards.
But technology is expensive and controlled by others. Patents make it costly. Trade agreements restrict copying. The digital platforms that dominate the global economy extract data and profits from developing countries and return them to shareholders in San Francisco and Shenzhen.
What can developing countries do?
Invest in education. This is the foundation. Countries with educated populations can absorb, adapt, and eventually generate technology. Countries without education are permanent technology importers.
Build research capacity. Even if a country cannot lead global R&D, it can build the capacity to adapt technology to local conditions, to modify and improve it, to eventually innovate on its own.
Use technology strategically. India's approach to generic drugs — respecting the letter of patent law while exploiting every flexibility to make drugs affordable — is a model of strategic technology policy.
Develop digital public infrastructure. India's success with Aadhaar (digital identity), UPI (digital payments), and CoWIN (vaccine management) shows how developing countries can build digital systems that serve their populations without depending entirely on foreign platforms.
Negotiate collectively. Individual developing countries have little leverage against multinational tech companies or the governments that back them. Collective action — through the WTO, through regional blocs, through issue-specific coalitions — can change the rules.
The Bigger Picture
Technology is not neutral. It is a product of human choices — about what to research, what to fund, what to patent, what to share, and what to withhold.
The countries that control technology today got there, in many cases, by acquiring it from others — sometimes legally, sometimes not. They now insist on rules that make it harder for today's developing countries to follow the same path.
This is not a reason for despair. It is a reason for strategic clarity.
Technology is the lever that moves the world. The question for every society is whether it is on the right end of that lever — pushing — or on the wrong end — being moved.
The farmer in Bihar checking crop prices on a mobile phone is using technology. But the real profits from that technology flow to Samsung (which made the phone), Google (which runs the operating system), and the telecom company (which sells the data plan).
The question is not whether to use technology — that is not optional. The question is whether to remain a consumer of other people's technology or to become a creator of your own.
Every country that is rich today answered that question by becoming a creator. The tools they used — education, research, industrial policy, and yes, strategic acquisition of others' technology — are the same tools available to developing countries today.
The rules may have changed. The ladder may have been kicked away. But the destination remains the same.
"The best way to predict the future is to invent it." — Alan Kay
And the best way to control your economic destiny is to control the technology that shapes it.
This concludes Part VI: Making Things. We have traveled from the farmer's impossible equation, through the Green Revolution, through industrialization and the resource curse, through energy and technology. The thread connecting all of it is simple: what you make determines what you earn. What you know determines what you can make. And who controls the knowledge determines who prospers.
In Part VII, we turn to trade — the system through which nations exchange what they make. As we will see, the rules of trade are not neutral either. They are written by the powerful, for the powerful. Understanding them is essential for anyone who wants to understand why the world is the way it is.